p38γ MAPK regulation of glucose transporter expression and glucose uptake in L6 myotubes and mouse skeletal muscle
暂无分享,去创建一个
N. Fujii | L. Goodyear | M. Hirshman | R. C. Ho | O. Alcázar
[1] H. Koistinen,et al. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients , 2003, Diabetologia.
[2] Y. Le Marchand-Brustel,et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.
[3] Y. Gotoh,et al. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. , 2003, Molecular endocrinology.
[4] Richard J Sciotti,et al. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. , 2003, Diabetes.
[5] R. Somwar,et al. A Dominant-negative p38 MAPK Mutant and Novel Selective Inhibitors of p38 MAPK Reduce Insulin-stimulated Glucose Uptake in 3T3-L1 Adipocytes without Affecting GLUT4 Translocation* , 2002, The Journal of Biological Chemistry.
[6] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[7] Min Huang,et al. Inhibition of Nucleoside Transport by p38 MAPK Inhibitors* , 2002, The Journal of Biological Chemistry.
[8] C. D. dos Remedios,et al. Cardiac expression and subcellular localization of the p38 mitogen-activated protein kinase member, stress-activated protein kinase-3 (SAPK3). , 2002, Journal of molecular and cellular cardiology.
[9] R. Somwar,et al. GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. , 2001, The Biochemical journal.
[10] S. Froehner,et al. In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4 , 2001, The Journal of cell biology.
[11] S. Baldwin,et al. Hyperosmotic shock induces both activation and translocation of glucose transporters in mammalian cells , 2001, Pflügers Archiv.
[12] Y. Gotoh,et al. MKK6/3 and p38 MAPK Pathway Activation Is Not Necessary for Insulin-induced Glucose Uptake but Regulates Glucose Transporter Expression* , 2001, The Journal of Biological Chemistry.
[13] N. Webster,et al. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. , 2000, Diabetes.
[14] R. Somwar,et al. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport. , 2000, Diabetes.
[15] R. Fielding,et al. Marathon running transiently increases c‐Jun NH2‐terminal kinase and p38γ activities in human skeletal muscle , 2000, The Journal of physiology.
[16] B. Foxwell,et al. The Pyridinyl Imidazole Inhibitor SB203580 Blocks Phosphoinositide-dependent Protein Kinase Activity, Protein Kinase B Phosphorylation, and Retinoblastoma Hyperphosphorylation in Interleukin-2-stimulated T Cells Independently of p38 Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.
[17] D. Alessi,et al. Effect of Contraction on Mitogen-activated Protein Kinase Signal Transduction in Skeletal Muscle , 2000, The Journal of Biological Chemistry.
[18] J. A. Badwey,et al. Activation of p90RSK and cAMP response element binding protein in stimulated neutrophils: novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade. , 1999, Journal of immunology.
[19] Tatsuya Hayashi,et al. Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. , 1999, American journal of physiology. Cell physiology.
[20] P. Cohen,et al. Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. , 1999, The Journal of biological chemistry.
[21] P. Cohen,et al. Stress-activated Protein Kinase-3 Interacts with the PDZ Domain of α1-Syntrophin , 1999, The Journal of Biological Chemistry.
[22] R. Somwar,et al. An Inhibitor of p38 Mitogen-activated Protein Kinase Prevents Insulin-stimulated Glucose Transport but Not Glucose Transporter Translocation in 3T3-L1 Adipocytes and L6 Myotubes* , 1999, The Journal of Biological Chemistry.
[23] I. Nonaka,et al. α1-Syntrophin Gene Disruption Results in the Absence of Neuronal-type Nitric-oxide Synthase at the Sarcolemma but Does Not Induce Muscle Degeneration* , 1999, The Journal of Biological Chemistry.
[24] A. Clerk,et al. The p38‐MAPK inhibitor, SB203580, inhibits cardiac stress‐activated protein kinases/c‐Jun N‐terminal kinases (SAPKs/JNKs) , 1998, FEBS letters.
[25] Roger J. Davis,et al. Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6* , 1998, The Journal of Biological Chemistry.
[26] Yong Jiang,et al. Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ* , 1997, The Journal of Biological Chemistry.
[27] C. Manthey,et al. Molecular Cloning and Characterization of a Novel p38 Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[28] T. Hunter,et al. p38-2, a Novel Mitogen-activated Protein Kinase with Distinct Properties* , 1997, The Journal of Biological Chemistry.
[29] Philip R. Cohen,et al. Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases , 1997, The EMBO journal.
[30] Tomoko Nakanishi,et al. ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.
[31] J. Miyazaki,et al. Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. , 1997, Biochemical and biophysical research communications.
[32] R. Fielding,et al. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. , 1997, The Journal of clinical investigation.
[33] Philip R. Cohen,et al. Activation of stress‐activated protein kinase‐3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) , 1997, The EMBO journal.
[34] Jiahuai Han,et al. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. , 1996, Biochemical and biophysical research communications.
[35] D. Moller,et al. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. , 1996, The American journal of physiology.
[36] Wei Guo,et al. Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.
[37] A. Ullrich,et al. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[39] Jiahuai Han,et al. Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.
[40] G. Reaven,et al. Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.
[41] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[42] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[43] J. Pouysségur,et al. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[44] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[45] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[46] Yamamura Ken-ichi,et al. Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5 , 1989 .
[47] R. DeFronzo,et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.
[48] D. James,et al. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. , 1985, The American journal of physiology.
[49] R. DeFronzo,et al. The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.
[50] R. Somwar,et al. Activation of p 38 Mitogen-Activated Protein Kinase and by Insulin and Contraction in Rat Skeletal Muscle Potential Role in the Stimulation of Glucose Transport , 2000 .
[51] H. Aihara,et al. Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.
[52] R. DeFronzo,et al. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.